Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review
September 2018
48
About the Report
About the Report
Innoviva Inc (INVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Innoviva Inc (Innoviva) develops and commercializes small molecule medicines. It focuses on products for various respiratory disorders. The company partners with GSK for the commercialization and development of all its products. It receives royalty payments for its collaboration with GSK. Innoviva is headquartered in Brisbane, California, the US.
Innoviva Inc Key Recent Developments
Jul 25,2018: Innoviva Reports Second Quarter 2018 Financial Results
May 22,2018: Innoviva Names Geoffrey Hulme as Interim Principal Executive Officer
Apr 26,2018: Innoviva Reports First Quarter 2018 Financial Results
Feb 08,2018: Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results
Dec 19,2017: Innoviva and Sarissa Implement Court Order
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Innoviva Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Titan Pharmaceuticals Inc
Teva Biopharmaceuticals USA Inc
Novartis Corp
Merck & Co Inc
Boehringer Ingelheim Corp
AstraZeneca LP
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Innoviva Inc-Key Facts 6
Innoviva Inc-Key Employees 7
Innoviva Inc-Key Employee Biographies 8
Innoviva Inc-Major Products and Services 9
Innoviva Inc-History 10
Innoviva Inc-Company Statement 11
Innoviva Inc-Locations And Subsidiaries 14
Head Office 14
Section 2-Company Analysis 15
Company Overview 15
Innoviva Inc-Business Description 16
R&D Overview 16
Innoviva Inc-Corporate Strategy 17
Innoviva Inc-SWOT Analysis 18
SWOT Analysis-Overview 18
Innoviva Inc-Strengths 18
Innoviva Inc-Weaknesses 19
Innoviva Inc-Opportunities 20
Innoviva Inc-Threats 21
Innoviva Inc-Key Competitors 22
Section 3-Company Financial Ratios 23
Financial Ratios-Capital Market Ratios 23
Financial Ratios-Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios-Interim Ratios 28
Financial Ratios-Ratio Charts 29
Section 4-Company's Lifesciences Financial Deals and Alliances 30
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Innoviva Inc, Recent Deals Summary 32
Section 5-Company's Recent Developments 33
Jul 25, 2018: Innoviva Reports Second Quarter 2018 Financial Results 33
Jul 25, 2018: Innoviva Reports Second Quarter 2018 Financial Results 34
Jul 25, 2018: Innoviva Reports Second Quarter 2018 Financial Results 35
Jul 25, 2018: Innoviva Reports Second Quarter 2018 Financial Results 36
Jul 25, 2018: Innoviva Reports Second Quarter 2018 Financial Results 37
May 22, 2018: Innoviva Names Geoffrey Hulme as Interim Principal Executive Officer 38
Apr 26, 2018: Innoviva Reports First Quarter 2018 Financial Results 39
Feb 08, 2018: Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results 40
Dec 19, 2017: Innoviva and Sarissa Implement Court Order 42
Oct 25, 2017: Innoviva Reports Third Quarter 2017 Financial Results and Provides Business Updates 43
Section 6-Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Figure
List of Figures
Innoviva Inc, Performance Chart (2013-2017) 27
Innoviva Inc, Ratio Charts 29
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Innoviva Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31
List of Table
List of Tables
Innoviva Inc, Key Facts 6
Innoviva Inc, Key Employees 7
Innoviva Inc, Key Employee Biographies 8
Innoviva Inc, Major Products and Services 9
Innoviva Inc, History 10
Innoviva Inc, Key Competitors 22
Innoviva Inc, Ratios based on current share price 23
Innoviva Inc, Annual Ratios 24
Innoviva Inc, Annual Ratios (Cont...1) 25
Innoviva Inc, Annual Ratios (Cont...2) 26
Innoviva Inc, Interim Ratios 28
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Innoviva Inc, Recent Deals Summary 32
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.